Testing effectiveness (Phase 2)Ended earlyNCT01636843
What this trial is testing
A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate
Who this might be right for
InflammationRheumatoid Arthritis
Novo Nordisk A/S 298